Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Novo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

Recent consumer research by product development group AMC Global and OpinionRoute, LLC reveals the evolving preferences of ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

Fact checked by Nick Blackmer Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but ...

A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...

The most popular weight-loss drugs are made by Novo Nordisk, which sells its medicine as Wegovy for obesity and ... are inferior to consuming healthy food. The drugs have been shown in clinical ...